Publications by authors named "Jeffrey A Cohen"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

75,033

Total Likes

1,796

Extended Reach

513,788

Social Features

122
O
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Jeffrey A Cohen, Giancarlo Comi, Jorge Correale, Patricia K Coyle, Anne H Cross, Jerome de Seze, David Leppert, Xavier Montalban

August 2020

Videos about Article: user user

2 1 5 119 4 141

View All Article and Social Media Activity
V
Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD, MS and Healthy Controls, and Disability Associations.
Amy Kunchok, Moein Amin, Tatchaporn Ongphichetmetha, Mengke Du, Robert Bermel, Jeffrey A Cohen

Ann Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.
Krzysztof W Selmaj, Lawrence Steinman, Giancarlo Comi, Amit Bar-Or, Douglas L Arnold, Jeffrey A Cohen

Mult Scler· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, Jeffrey A Cohen, Zachary S Wallace

JCI Insight· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 revision of the McDonald diagnostic criteria for MS: Substantial and substantive changes.
Jeffrey A Cohen

Mult Scler· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis.
Stephen L Hauser, Jeffrey A Cohen, Jérôme de Sèze, Sven G Meuth, Paul S Giacomini

Neurol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Effectiveness and Tolerability of Novel Monoclonal Antibodies and Rituximab for NMOSD.
Zarmina Javed, Mengke Du, Mary Rensel, Le H Hua, Carrie M Hersh, Jeffrey A Cohen

Ann Clin Transl Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of Seroconversion in Aquaporin-4 Antibody Testing: Insights From Real-World Data.
Tatchaporn Ongphichetmetha, Mengke Du, Nisa Vorasoot, Sean J Pittock, Jeffrey A Cohen

Ann Clin Transl Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria.
Xavier Montalban, Christine Lebrun-Frénay, Jiwon Oh, Georgina Arrambide, Marcello Moccia, Jeffrey A Cohen

Lancet Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous haematopoietic stem cell transplantation in multiple sclerosis: where does it fit in the treatment algorithm?
Amjad Samara, Jeffrey A Cohen

J Neurol Neurosurg Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trials.
Jeffrey A Cohen, Douglas L Arnold, John DeLuca, Hans-Peter Hartung, Ludwig Kappos

Mult Scler· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive and Patient-Reported Outcome Measures in LGI-1-IgG Autoimmune Encephalitis.
Tatchaporn Ongphichetmetha, Carol Swetlik, Nicolas Thompson, Albert Aboseif, Vineet Punia, Jeffrey A Cohen

Ann Clin Transl Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic diseases misdiagnosed as multiple sclerosis: Observational study and review of literature.
Daniele Mandia, Natalia Shor, Alise K Carlson, Emmanuel Obusez, Jeffrey A Cohen

Mult Scler Relat Disord· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glial Fibrillary Acidic Protein as a Marker of Disease in Relapsing Multiple Sclerosis: Post Hoc Analysis of Phase 3 Ozanimod Trials.
Sarah Harris, Giancarlo Comi, Bruce A C Cree, Douglas L Arnold, Lawrence Steinman, Jeffrey A Cohen

Eur J Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.

JAMA Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors.
Saira Afzal, Yadi Li, Brittany Lapin, Le H Hua, Lucy Boyce Kennedy, Jeffrey A Cohen

Ann Clin Transl Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT.
Paolo A Muraro, Alice Mariottini, Raffaella Greco, Joachim Burman, Ellen Iacobaeus, Jeffrey A Cohen

Nat Rev Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive Myelitis in a 63-Year-Old Woman: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings.
Kimberly A DiMauro, Morgan E Heber, Jonathan Lee, Jeffrey A Cohen, Eoin P Flanagan

Neurol Neuroimmunol Neuroinflamm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Outcomes in Myelin Oligodendrocyte Glycoprotein-IgG Associated Disease Compared to Multiple Sclerosis.
Eileen Galvani, Jeffrey A Cohen, John T Martin, Kunio Nakamura, Amy Kunchok

Brain Behav· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.
Meggan Mackay, Catriona A Wagner, Ashley Pinckney, Jeffrey A Cohen, Zachary S Wallace

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The onset presentation of multiple sclerosis differs in Hispanic/Latinx Americans compared with non-Hispanic White Americans.
Farren Bs Briggs, Devon S Conway, Carrie M Hersh, Kathryn C Fitzgerald, Ellen Mowry, Jeffrey A Cohen

Mult Scler· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Sabrina Paganoni, Christina N Fournier, Eric A Macklin, Lori B Chibnik, Melanie Quintana, Jeffrey A Cohen

JAMA Netw Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.
John F Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey A Cohen, Douglas L Arnold

Neurol Neuroimmunol Neuroinflamm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analyte heterogeneity analysis as a possible potency parameter for MSC.
David Kaplan, Eric Christian, Sarah Planchon Pope, Hillard M Lazarus, Jeffrey A Cohen

Best Pract Res Clin Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis